Background
Criteria | Description |
---|---|
P (participants) | Non-carious human permanent teeth with DH |
I (Intervention) | DH treatment with CAREDYNE Shield |
C (Control) | DH treatment with Nanoseal |
O (Outcome) | The reduction of pain level in response to air stimuli |
Methods/design
Trial design
Participant timeline
Enrollment | Post allocation | |
---|---|---|
Time point | 0 | 4 weeks (range 3–5 weeks) |
Enrollment: | ||
Eligibility screen | X | |
Informed consent | X | |
Allocation | X | |
Intervention: | ||
CAREDYNE Shield | X | |
Nanoseal | X | |
Clinical assessment: | ||
Air blow | X | X |
Inspection | X | X |
Palpation | X | X |
Study setting
Sample size
Eligibility screen
Inclusion criteria | |
Outpatients | |
Participants who presented with a DH complaint | |
Participants who agreed to participate in this study after providing their informed consent | |
Exclusion criteria | |
Participants who have an allergy to the desensitizing materials used in this study | |
Participants who are pregnant or lactating | |
Participants who have undergone DH treatment within the last 6 months | |
Participants with systemic diseases that might influence the results of this study | |
Participants who present with pain complaints that might influence the results of this study | |
DH teeth with restoration that might influence the results of this study | |
DH teeth with caries or advanced periodontal disease | |
DH teeth that have undergone periodontal surgery or orthodontic treatment within the last 3 months |
Informed consent
Randomized allocation
Material | Manufacturer | Composition |
---|---|---|
CAREDYNE Shield | GC Dental Industrial Corporation, Tokyo, Japan | Solution A: fluorozinccalciumsilicate glass Solution B: 10–15% phosphoric acid |
Nanoseal | Nippon Shika Yakuhin Co., Ltd., Shimonoseki, Japan | Solution A: fluoroaluminocalciumsilicate glass Solution B: 10% phosphoric acid |
Allocation concealment
Blinding of participants
Intervention
Primary outcome
Score | Level of pain intensity |
---|---|
0 | No pain |
1 | Mild pain |
2 | Moderate pain |
3 | Severe pain |
4 | Extremely intense pain |